Table 1.
Escape mutants selected on ND‐011992 + Q203 are resistant to Q203 but not to ND‐011992.†
Strain | MIC50 | ND‐011992 ATP IC50 (μM) | |
---|---|---|---|
Q203 (nM) | Lansoprazole (µM) | ||
Wild type | 0.0014 | 44.61 | 0.74 |
1 | >100 | 55.94 | 0.98 |
2 | >100 | 57.46 | 0.92 |
3 | >100 | 54.19 | 0.90 |
4 | >100 | 57.5 | 0.48 |
5 | >100 | 56.06 | 0.53 |
6 | >100 | 58.22 | 0.76 |
7 | >100 | 55.71 | 0.50 |
8 | >100 | 63.5 | 0.40 |
9 | >100 | 60.94 | 0.58 |
10 | >100 | 52.37 | 0.83 |
11 | >100 | 99.5 | 0.98 |
12 | >100 | 68.33 | 0.77 |
13 | >100 | 62.92 | 0.67 |
14 | >100 | 63.62 | 0.87 |
15 | >100 | 63.88 | 0.56 |
16 | >100 | 64.38 | 0.38 |
17 | >100 | 63.79 | 0.60 |
18 | >100 | 62.87 | 0.46 |
The M. bovis BCG spontaneous‐resistant mutant strains were exposed to a dose range of Q203 or lansoprazole for 5 days before recording the turbidity at OD600. The potency of ND‐011992 was tested in an ATP depletion assay in combination with lansoprazole. Bacteria were exposed to a dose range of ND‐011992 in the presence of lansoprazole at 200 µM for 15 h before quantification of intracellular ATP levels. The experiments were performed in duplicates and repeated once.